State of New Jersey Common Pension Fund D Cuts Stake in Addus HomeCare Co. (NASDAQ:ADUS)

State of New Jersey Common Pension Fund D reduced its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 11.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 14,911 shares of the company’s stock after selling 1,853 shares during the period. State of New Jersey Common Pension Fund D’s holdings in Addus HomeCare were worth $1,984,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in ADUS. Crossmark Global Holdings Inc. purchased a new stake in Addus HomeCare during the third quarter valued at about $228,000. TimesSquare Capital Management LLC lifted its stake in shares of Addus HomeCare by 2.4% in the 3rd quarter. TimesSquare Capital Management LLC now owns 276,915 shares of the company’s stock valued at $36,838,000 after acquiring an additional 6,490 shares during the last quarter. Assetmark Inc. boosted its holdings in Addus HomeCare by 11.5% during the 3rd quarter. Assetmark Inc. now owns 1,169 shares of the company’s stock valued at $156,000 after acquiring an additional 121 shares during the period. Equitable Trust Co. grew its position in Addus HomeCare by 2.2% during the 3rd quarter. Equitable Trust Co. now owns 4,825 shares of the company’s stock worth $642,000 after acquiring an additional 106 shares during the last quarter. Finally, Principal Financial Group Inc. increased its stake in Addus HomeCare by 17.5% in the 3rd quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock worth $67,293,000 after purchasing an additional 75,409 shares during the period. 95.35% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Addus HomeCare

In other Addus HomeCare news, Director Esteban Lopez sold 500 shares of the business’s stock in a transaction on Wednesday, September 4th. The stock was sold at an average price of $130.03, for a total value of $65,015.00. Following the sale, the director now directly owns 3,866 shares of the company’s stock, valued at approximately $502,695.98. The trade was a 11.45 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the firm’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the transaction, the executive vice president now owns 7,215 shares of the company’s stock, valued at $961,687.35. The trade was a 75.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 22,917 shares of company stock valued at $3,050,082 in the last ninety days. 4.60% of the stock is currently owned by corporate insiders.

Addus HomeCare Stock Down 1.9 %

NASDAQ ADUS opened at $119.78 on Friday. The stock’s 50 day moving average is $128.99 and its 200 day moving average is $122.42. The firm has a market capitalization of $2.17 billion, a PE ratio of 27.41, a P/E/G ratio of 2.15 and a beta of 1.04. Addus HomeCare Co. has a twelve month low of $85.43 and a twelve month high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. The company had revenue of $289.80 million during the quarter, compared to analysts’ expectations of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. Addus HomeCare’s revenue was up 7.1% on a year-over-year basis. During the same period last year, the company posted $1.03 EPS. On average, research analysts anticipate that Addus HomeCare Co. will post 4.58 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the stock. KeyCorp initiated coverage on shares of Addus HomeCare in a report on Friday, October 11th. They issued an “overweight” rating and a $150.00 target price on the stock. Royal Bank of Canada reissued an “outperform” rating and issued a $136.00 price target on shares of Addus HomeCare in a report on Thursday. Stephens upped their price objective on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a research note on Wednesday, November 6th. TD Cowen raised their target price on Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a research note on Thursday, August 8th. Finally, Oppenheimer upped their price target on Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research report on Monday, September 23rd. One research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, Addus HomeCare has an average rating of “Moderate Buy” and a consensus price target of $131.63.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.